Anne-Marie Duliege, Chief Medical Officer at RIGEL PHARMACEUTICALS INC (RIGL), sold 5,000 shares at $2.41 ($12K) on 2017-01-03, disclosed to the SEC on 2017-01-13.
Scheduled sale ($12k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RIGL | SELL | 2018-07-05 | $14K | — | Filing → |
| RIGL | SELL | 2018-04-24 | $21K | — | Filing → |
| RIGL | SELL | 2017-07-07 | $13K | — | Filing → |